Scipher Medicine Welcomes Chief Technology Officer
Summary
WALTHAM, Mass.--(BUSINESS WIRE)--Scipher Medicine, developer of a molecular technology platform used to ensure patients are prescribed most effective therapy, today announces the addition of Slava Akmaev, Ph.D. as Chief Technology Officer to the growing leadership team. “Having committed and talented individuals such as Slava on our team will help propel us towards our mission of improving patient outcomes and usher in a new era of precision medicine, one capable of providing better solutions for complex diseases,” said Alif Saleh, Chief Executive Officer of Scipher Medicine. Dr. Akmaev is a leader in applying high-throughput molecular technology, machine learning, artificial intelligence and data analysis within the life sciences and healthcare industry. “The path Scipher is taking to personalize medicine in a way that puts the molecular biology of each patient at the center of the treatment decision is something I have wanted to do for more than a decade,” said Akmaev. With artificial intelligence and its proprietary molecular technology platform, Scipher Medicine develops innovative diagnostic tests that predict which drug will work from day one and use the data from these tests to develop more effective therapies to improve patient outcomes.